Clinical Trial Update: Relative Bioavailability of Olodaterol and Fluconazole [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the pharmacokinetic interaction and relative bioavailability of olodaterol and fluconazole in healthy subjects and patients with chro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Diflucan (Fluconazole)
• Striverdi Respimat (olodaterol)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Healthy, Pulmonary Disease, Chronic Obstructive | Phase 1 | Status: COMPLETED | Results posted: 2014-06-10